Main Article Content

Zainab H. Al-Mussa
Hawazin Y. Thamair


HBV, HCV, prevalence of hepatitis virus, Basrah


Background: This prospective descriptive study was carried out in the Basra Public Health Department fromAugust 2017 to August 2018 on all patients registered at the Communicable Disease Control unit.
Aim of the study. is to detect the prevalence rate of hepatitis c virus among risky group and to determined the most common risk factors.
Patients and method.A total of 162137 (97283 male and 64854 female) people were screened and 355 (205 male and 150 female) people were found to be infected. The laboratory investigation included a blood sample to detect anti-hepatitis C virus antibodies by using an enzyme-linked immunosorbent assay test, which is a confirmatory test for those with positive results found using the HCV RNA genotype.
Result. In this study, we found that the prevalence rate of the hepatitis C virus in Basra city among the screening group was 2% in comparison with the global population affected by this diseasebeing a little more than 3%. The most common risk factor for infection with the hepatitis C virus is dentinal interference (83 patients) with 23% affected cases, while the lowest risk factor is in prisoners. Among patients with cancer, the most common age group at the risk of infection with hepatitis C is 15 to less than 45 years and 0.5%. The number of infected people in rural areas is greater than in the center with a prevalence rate of 0.22% in Al-Qurna. The most common risky group exposed to infection are hemodialysis patient( prevalence rate 84.5%).
Conclusion. It’s important to apply a screening program of hepatitis C to all population to have a more quorate prevalence rate; population health education about the risk factor of infection with hepatitis C and how to prevent it; a strict follow-up of all dentinal clinics by the health directorate and insure the use of sterilized instrument for every patient; use of disposable instrument in dentinal clinic if possible; early screening for renal disease is necessary to prevent the development of renal failure and its complication.

Abstract 374 | Full text PDF Downloads 8


1- Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. Journal of hepatology. 2006 Oct 1;45(4):529-38.
2- Statistics & Surveillance Division of Viral Hepatitis CDC". CDC. Archived from the original on 2016 Nov 11 .
3- Aljarbou AN. Current prevalence of HBV and HCV seropositivity: The initiative for attentiveness and deterrence of viral hepatitis in the Qassim region of Saudi Arabia. J Antivir Antiretrovir. 2012;4(4):75-9.
4- Armstrong, Gregory L, et al. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Annals of internal medicine. 144.10 (2006): 705-714.‏
5- Schreiber GB. The risk of transfusion-transmitted viral infections. The Epidemiology Donor Study. N Engl J Med. 1996;334(26):1734-5.
6- Hajarizadeh B, Grebely J, Dore GJ. Epidemiology and natural history of HCV infection. Nature Reviews Gastroenterology & Hepatology. 2013 Sep;10(9):553.
7- Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: New estimates of age‐specific antibody to HCV seroprevalence. Hepatology. 2013 Apr;57(4):1333-42.
8- Global Burden of Disease Hepatitis C Working Group (GBD) for hepatitis C. Journal of Clinical Pharmacology. 2004;44(1):20-29.
9- Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-Related Chronic Disease. MMWR. 47: 1–39. 1998 Oct 16. PMID 9790221
10- Neelam M, Suchet sachev. Current testing strategies for hepatitis C virus infection in blood donors and the way forward. World Journal of Gastroenterology: WJG,2014
11- Kiyosawa, Kendo, et al. Hepatitis C in hospital employees with needlestick injuries." Annals of internal medicine. 1991. 115.5: 367-369.
12- Hepatitis C guidance: American Association for the Study of Liver Diseases (AASLD) and the Infectious Diseases Society of America (IDSA). Recommendations for testing, management, and treating hepatitis C. HCV testing and linkage to care. Available at: 25 June 2015,
13- Alter MJ. Epidemiology of hepatitis C virus infection. World journal of gastroenterology: WJG. 2007 May 7;13(17):2436
14- Ashkani-Esfahani S, Alavian SM, Salehi-Marzijarani M. Prevalence of hepatitis C virus infection among hemodialysis patients in the Middle-East: A systematic review and meta-analysis. World journal of gastroenterology. 2017 Jan 7;23(1):151.
15- Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. Journal of viral hepatitis. 2004 Mar;11(2):97-107.
16- Allain JP, Mihaljevic I, Gonzalez‐Fraile MI, Gubbe K, Holm‐Harritshøj L, Garcia JM, Brojer E, Erikstrup C, Saniewski M, Wernish L, Bianco L. Infectivity of blood products from donors with occult hepatitis B virus infection. Transfusion. 2013 Jul;53(7):1405-15.

17- Castiglia P, Liguori G, Montagna MT, Napoli C, Pasquarella C, Bergomi M, Fabiani L, Monarca S, Petti S. Italian multicenter study on infection hazards during dental practice: control of environmental microbial contamination in public dental surgeries. BMC public health. 2008 Dec;8(1):187.

Similar Articles

1-10 of 54

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 9 10 > >>